A decision in the matter of the International Association of Athletics Federations (IAAF) v Jarrion Lawson has been issued by the Disciplinary Tribunal. Jarrion Lawson, an American long jumper/sprinter was charged by the Athletics Integrity Unit (AIU) under the IAAF Anti-Doping Rules (ADR) after testing positive for the presence of epitrenbolone (which is listed in S1.1a. Exogenous Anabolic Androgenic Steroids of the World Anti-Doping Agency 2018 Prohibited List) in a urine sample collected on 2 June 2018.
On 26 April 2019, a hearing was held in New York before the Tribunal consisting of Michael J. Beloff QC (Chair), Jeffrey Benz and Francisco A. Larios. The Panel found that the Athlete had committed Anti-Doping Rule Violations pursuant to Articles 2.1 and Art 2.2 ADR, and a four (4) year period of ineligibility has been imposed upon Mr. Jarrion Lawson, commencing on the date of the Tribunal Award. The period of Provisional Suspension imposed on the Athlete from August 3, 2018 until the date of the Tribunal Award shall be credited against the total period of ineligibility, provided that it has been effectively served.
Mr. Jarrion Lawson’s results from June 2, 2018 until the date of his Provisional Suspension on August 3, 2018 shall be disqualified with all resulting consequences including the forfeiture of any titles, awards, medals, points and prize and appearance money pursuant to Article 10.8 ADR.
A copy of the full decision can be accessed via the related links tab on the right-hand side.
To go to the AIU's website please click here.